XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
XORTX Therapeutics Inc. reported a decrease in total assets to $3.85 million as of September 30, 2024, compared to $5.47 million at the end of 2023, alongside an increased derivative warrant liability. The company’s current liabilities rose significantly, highlighting financial challenges amid ongoing research and development expenses.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.